Related Experiment Video

Updated: Apr 8, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

From standard to new genome-based therapy of gastric cancer

Georgios D Lianos1, Alberto Mangano, William C Cho

  • 1Centre for Biosystems and Genomic Network Medicine, University of Ioannina, Ioannina, Greece.

Expert Review of Gastroenterology & Hepatology
|June 26, 2015
PubMed

Insights

Personalized prediction of treatment resistance and recurrence in gastric cancer remains challenging. Next-generation sequencing offers novel clinical approaches for improved gastric cancer treatment strategies.

Area of Science:

  • Oncology
  • Gastroenterology
  • Genomics

Background:

  • Established multidisciplinary treatments for gastric cancer include surgery, radiotherapy, chemotherapy, and targeted therapy.
  • Current treatment strategies face limitations in predicting therapeutic resistance and disease progression.
  • Personalized prediction of treatment outcomes for gastric cancer is an ongoing research goal.

Discussion:

  • Review of standard gastric cancer treatment modalities and their inherent limitations.
  • Exploration of challenges in predicting patient response and disease recurrence.
  • Highlighting the need for advanced diagnostic and predictive tools in gastric cancer care.

Key Insights:

  • Next-generation sequencing (NGS) technology holds promise for personalized gastric cancer treatment.
  • NGS enables a deeper understanding of tumor heterogeneity and molecular drivers.
  • Potential for improved prediction of therapeutic resistance and patient stratification using genomic data.

Outlook:

  • Future gastric cancer treatment will likely integrate genomic insights from NGS.
  • Development of novel, personalized therapeutic strategies based on NGS findings.
  • Advancing clinical approaches for better management of gastric cancer recurrence and metastasis.
Keywords:
cancer biomarkersgastric cancergenome-based therapynext-generation sequencing analysespersonalized cancer medicinewhole-exome sequencingwhole-genome sequencing

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.3K
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.2K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
88